Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous

Gianluca Campo1, Paolo Guastaroba2, Antonio Marzocchi3

  • 1Cardiovascular Institute, Azienda Ospedaliero-Universitaria S.Anna, Ferrara; LTTA center, Ferrara.

Chest
|February 9, 2013
PubMed

Insights

Patients with ST-segment elevation myocardial infarction (STEMI) and chronic obstructive pulmonary disease (COPD) face higher mortality and readmission risks. COPD exacerbations significantly increase the risk of death, recurrent heart attack, heart failure, and bleeding.

Area of Science:

  • Cardiology
  • Pulmonology
  • Public Health

Background:

  • Limited data exist on the long-term outcomes for patients experiencing ST-segment elevation myocardial infarction (STEMI) with co-existing chronic obstructive pulmonary disease (COPD).
  • Understanding these outcomes is crucial for improving patient care and management strategies.

Purpose of the Study:

  • To evaluate the long-term prognosis of patients with STEMI and concomitant COPD.
  • To assess the impact of COPD on mortality and hospital readmissions following STEMI.

Main Methods:

  • A cohort of 11,118 STEMI patients from the REAL registry were followed for 3 years.
  • Patients were stratified based on the presence or absence of COPD.
  • Outcomes assessed included mortality and hospital readmissions for myocardial infarction (MI), heart failure (HF), coronary revascularization (CR), serious bleeding (SB), and COPD.

Main Results:

  • 18.2% of patients had COPD. COPD was an independent predictor of mortality (HR, 1.4).
  • Patients with COPD had significantly higher readmission rates for recurrent MI, CR, HF, and SB.
  • COPD readmissions were frequent (19% vs 3%) and strongly predicted death (HR, 4.2), recurrent MI (HR, 2.1), HF (HR, 5.8), and SB (HR, 3).

Conclusions:

  • Patients with STEMI and COPD face elevated risks of death and cardiovascular-related hospital readmissions compared to those without COPD.
  • COPD exacerbations are a significant independent risk factor for adverse outcomes, including mortality, recurrent MI, HF, and serious bleeding.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...